CoChat

Fecal microbiota transplantation: facts and controversies

Open access
van Nood, Els, Speelman, Peter, Nieuwdorp, Max, Keller, Josbert · 2014 · Current Opinion in Gastroenterology

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

PURPOSE OF REVIEW: To review the current evidence on fecal microbiota transplantations (FMTs) for recurrent Clostridium difficile infections (CDIs), metabolic syndrome and inflammatory bowel disease. RECENT FINDINGS: Recently, a randomized trial confirmed the efficacy of this treatment strategy in patients with recurrent CDI. For other disorders, evidence is still limited. To date, studies have been performed to try and influence the course of metabolic syndrome and inflammatory bowel disease. SUMMARY: There is increasing interest in the role of altered microbiota in the development of a myriad of diseases. Together with new insights comes an interest in influencing this altered microbiota as a potential target for therapy. FMTs are effective against recurrent CDI, a disorder caused by disruption of the normal microbiota. Restoration of intestinal flora and thereby restoration of colonization resistance is thought to be the mechanism responsible for cure. With the developments in FMT and the extension of this treatment modality to both intestinal and extra-intestinal diseases, a new field of targeted therapy awaits. The ultimate goal is the development of powerful probiotic regimens that can replace FMT. Currently, FMT should only be given in a strict experimental setting for other conditions than CDI.

Overview

Integrity signals

Registry

Crossref · 10.1097/mog.0000000000000024

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 28 references

Research works printed but not linked: 6

  1. Zhang, 2012, astroenterol, 107, 1755
  2. Eiseman, 1958, Surgery, 44, 854
  3. van Nood, 2009, urveill, 14, 19316
  4. Vrieze, 2013, astroenterol, 27, 127
  5. Knaapen, 2013, nfect, 19, 331
  6. Kahn, 2012, is, 18, 676

Cited by

See all 92

Metadata

Authors
van Nood, E., Speelman, P., Nieuwdorp, M., & Keller, J.
Affiliations
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Haga Hospital (NL)
Venue
Current Opinion in Gastroenterology
Published
2014-01
Volume
30
Issue
1
Pages
34-39
ISSN
0267-1379 (ISSN-L)
OpenAlex
W2321884843
Cited by
92
References
28
Citations by year
2026: 1 · 2025: 1 · 2023: 8 · 2022: 6 · 2021: 4 · 2020: 7 · 2019: 6 · 2018: 7 · 2017: 13 · 2016: 7 · 2015: 19 · 2014: 13
FWCI
1.69
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Current Opinion in Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
fecal microbiota transplantation, recurrent Clostridium difficile infection, metabolic syndrome, inflammatory bowel disease, gut microbiota, colonization resistance, probiotics, microbiota-targeted therapy
MeSH terms
Clinical Protocols, Enterocolitis, Pseudomembranous, Feces, Humans, Intestines, Recurrence, Inflammatory Bowel Diseases, Tissue Transplantation, Metabolic Syndrome, Donor Selection, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fecal microbiota transplantation: facts and controversies. https://app.cochat.ai/papers/10.1097/mog.0000000000000024
The paper
van Nood, E., Speelman, P., Nieuwdorp, M., & Keller, J. (2014). Fecal microbiota transplantation: facts and controversies. Current Opinion in Gastroenterology. https://doi.org/10.1097/mog.0000000000000024

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.